Presented by: Eric Paul & Brad Rogers
|
|
- Sheena Anthony
- 5 years ago
- Views:
Transcription
1 Improving the Quality of your Life Presented by: Eric Paul & Brad Rogers 1
2 A focused medical approach to meet the specific needs of the physicians and patients Standardized Products provide us the ability to Label Claim on every SKU 2
3 Expanding our Global Network to capitalize on the $180B market opportunity - Joint Venture in Denmark with license to produce and sell medical cannabis Australia Germany Netherlands License to produce and sell medical cannabis Export partnership with one of the largest pharmaceutical distributors in the country Export and JV partnership for local cultivation 3
4 Our Global Pharmaceutical Partner Partnership to develop proprietary and novel dosage forms Distribution to 115 countries globally Accessibility to global regulatory 4
5 Key to CannTrust s success People Process Technology 5
6 Management Team People ERIC PAUL BRAD ROGERS IAN ABRAMOWITZ ILANA PLATT MICHAEL RAVENSDALE KAIVAN TALACHIAN JEFFREY ZIETLOW LEA ROMANELLI BERNARD YEUNG 6
7 People The team brings brand building experience in Canada and internationally across CPG, alcohol and major retailers 7
8 Organizational culture People All key aspects of the business, are fortified with subject matter experts DATA BASED DECISION MAKING 10 PHDs ON STAFF DOCTORS DETAILING DOCTORS EVERY EMPLOYEE IS AN OWNER 8
9 A broad portfolio to meet the needs of all our customers Approved for sale 9 # of Producers 105 producers 33 producers 2 producers CannTrust Patented 4 producers CannTrust only Vegan based capsule
10 Hard shell, banded, non-gelatin capsules 10mg doses available in THC, CBD and 1:1 Standardized formulations in easy convenient format 10
11 The landscape of growing facilities has changed rapidly over the past 4 years Indoor Facility Unimproved Greenhouse Outdoor CannTrust - Niagara Perpetual Harvest Greenhouse Category Measurement Category Measurement Category Measurement Category Measurement Yield (gram per sq ft annually) Yield (gram per sq ft annually) Yield (gram per sq ft annually) Yield (gram per sq ft annually) Crops per Year 4-5 Crops per Year 1-2 Crops per Year 1 Crops per Year 5-6 COGs ($/g) $1.60- $2.00 Percent of top grade flower 95% COGs ($/g) $0.95 Percent of top grade flower 50% COGs ($/g) $0.10 Percent of top grade flower 25% COGs ($/g) $0.75 Percent of top grade flower 95% High yield, high cost, 95% top grade flower Low yield, moderate cost, 50% of top grade flower Low yield, low cost, 25% of top grade flower High yield, moderate cost, 95% top grade flower 11
12 #1: Indoor Facility Category Yield (gram per sq ft annually) Measurement Crops per Year 4-5 COGs ($/g) $1.60- $2.00 Percent of top grade flower 95% High yield, high cost, 95% top grade flower 12
13 #2: Unimproved Greenhouse Category Yield (gram per sq ft annually) Measurement Crops per Year 1-2 COGs ($/g) $0.95 Percent of top grade flower 50% Low yield, moderate cost, 50% of top grade flower 13
14 #3 Outdoor Category Yield (gram per sq ft annually) Measurement Crops per Year 1 COGs ($/g) $0.10 Percent of top grade flower 25% Low yield, low cost, 25% of top grade flower 14
15 #4 CannTrust - Niagara Perpetual Harvest Greenhouse Category Yield (gram per sq ft annually) Measurement Crops per Year 5-6 COGs ($/g) $0.75 Percent of top grade flower 95% High yield, moderate cost,, 95% top grade flower 15
16 Technology It s REAL It s LICENSED It s PRODUCING 100,000 KGs 16
17 450,000 sq ft today (Niagara facility) Niagara expansion = 600,000 sq ft (Proprietary Genetics) 2019 projected production 100,000+ kgs 17
18 Process Perpetual Harvest Greenhouse Category Yield (gram per sq ft annually) Measurement 225 Crops per Year 5 Perpetual Harvest Projections Category Effective sq. ft of grow Measurement 350,000 sq ft Crops per Year 5 COGs ($/g) $0.75 Percent of top grade flower 95% Total annualized grow equivalency 1.75M sq ft High yield, moderate cost, 95% top grade flower Annualized square foot grow equivalency with over 95% top grade flower 18
19 Improving the Quality of your Life Medical and Recreational markets 19
20 Capsules and new products will drive global innovation in the medical market Extended release capsules Topicals and creams Nebulizers and inhalers 20
21 CannTrust is the exclusive provider of medical cannabis to over 300,000 plan members Electronic adjudication NexgenRx Services: Full benefit administrator Health claims adjudication Independent pharmacy benefit manager Health care spending accounts 21
22 CannTrust will have a strong market share in the recreational market, securing over 17,000 KGs in Western Canada, with more provinces to follow 22
23 3 NEW National Brands focused on 3 consumer segments Stimulate your social life Flavour focus for consumers Experiential focused Flix n Chill 23
24 CannTrust has developed formulations for all beverage categories, ready for the edible market once regulations change 24
25 Patent-pending Nano Technology process enables cannabis to be infused in all beverages and edible product categories Cannabis infused flavoured coolers / sparkling beverages Multi-serve for 1 oz servings, designer cannabinoids, 0 calorie formats Cannabis beer/ciders with no alcohol CBD Sports drinks for Athletic Recovery Edibles such as: chocolate and candy are ready to be produced once the regulations change in the next months 25
26 2019/2020: Brewbudz U.S. and Canadian Patent issued using a single-serve brewing pods for Keurig, Nespresso, Tassimo type brewers Successfully launched in U.S. market Single serve Pod will be offered in Canada when the edible market opens in 2019! 26
27 A global, veterinary-focused leader in the companion animal health cannabis market 27
28 Leading the global cannabis industry Foundation in Medical International expansion and RTM with Apotex Recreational, Innovation and new adjacent verticals 28
29 Improving the Quality of your Life Thank You 29
30 Disclaimers This presentation is for information only and shall not constitute an offer to buy, sell, issue or subscribe for, or the solicitation of an offer to buy, sell or issue, or subscribe for any securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The information contained herein is subject to change without notice and is based on publicly available information, internally developed data and other sources. Where any opinion or belief is expressed in this presentation, it is based on the assumptions and limitations mentioned herein and is an expression of present opinion or belief only. No warranties or representations can be made as to the origin, validity, accuracy, completeness, currency or reliability of the information. CannTrust Holdings Inc. ( CannTrust ) disclaims and excludes all liability (to the extent permitted by law), for losses, claims, damages, demands, costs and expenses of whatever nature arising in any way out of or in connection with the information in this presentation, its accuracy, completeness or by reason of reliance by any person on any of it. This presentation should not be construed as legal, financial or tax advice to any individual, as each individual s circumstances are different. Investors should consult with their own professional advisors regarding their particular circumstances. The information contained in this presentation is not directed to persons or entities resident in the United States and does not constitute an offer or solicitation by anyone in the United States or in any other jurisdiction in which such an offer or solicitation is not authorized or to any person to whom it is unlawful to make such an offer or solicitation, unless otherwise exempt from United States securities legislation. Forward-Looking Statement Certain statements in this presentation are forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always using words or phrases such as expect, seek, endeavour, anticipate, plan, estimate, believe, intend, or stating that certain actions, events or results may, could, would, might or will occur or be taken, or achieved) are not statements of historical fact and may be forward-looking statements. Forward-looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which would cause actual results or events to differ materially from those presently anticipated. Forward-looking statements are based on expectations, estimates and projections at the time the statements are made and involve significant known and unknown risks, uncertainties and assumptions. A number of factors could cause actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward- looking statements including but not limited to the risk factors set out in Appendix III of this presentation. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward- looking statements prove incorrect, actual results, performance or achievements could vary materially from those expressed or implied by the forward-looking statements contained in this document. These factors should be considered carefully and prospective investors should not place undue reliance on these forward-looking statements. Although the forward-looking statements contained in this document are based upon what CannTrust currently believes to be reasonable assumptions, CannTrust cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements. Except as required by law, CannTrust does not have any obligation to advise any person if it becomes aware of any inaccuracy in or omission from any forward-looking statement, nor does it intend, or assume any obligation, to update or revise these forward-looking statements to reflect new events or circumstances.
Nurturing Shareholder Growth
JULY 2018 Nurturing Shareholder Growth EMBLEM CORP. TSXV: EMC DISCLAIMER This documentation is a presentation (the Presentation ) of general background information about Emblem Corp s., ( Emblem ) activities
More informationTSX:LEAF Investor Presentation December 2017 Top Licensed Producer
TSX:LEAF Investor Presentation December 2017 Top Licensed Producer Price Close (Dec 7, 2017): $15.47 Market Capitalization: $1.5 billion Basic and F.D. Shares: 94.1/101.4 million Forward-Looking Information
More informationThe discussion and analysis in this MD&A is based on information available to management as of August 13, 2018.
MANAGEMENT'S DISCUSSION AND ANALYSIS This following Management's Discussion and Analysis provides a review of the financial condition and results of operations for CannTrust Holdings Inc. (the "Company"
More informationTSX:LEAF Investor Presentation March 2018
TSX:LEAF Investor Presentation March 2018 Price Close (Mar 16, 2018): $19.34 Market Capitalization: $1.9 billion Basic and F.D. Shares: 99.8/109.6 million Forward-Looking Information This Presentation
More informationInvestor Presentation August 23, 2017
Investor Presentation August 23, 2017 Forward-Looking Information This Presentation contains forward-looking information within the meaning of applicable Canadian securities legislation which are based
More informationTSX:LEAF Investor Presentation October 2017
TSX:LEAF Investor Presentation October 2017 Price Close (Oct 6, 2017): $9.80 Market Capitalization: $890 million Basic and F.D. Shares: 90.8/93.2 million Forward-Looking Information This Presentation contains
More informationInvestor Presentation. TSX Venture (OGI) OTCQX Best Market (OGRMF)
Investor Presentation TSX Venture (OGI) OTCQX Best Market (OGRMF) Disclaimer & Cautionary Statements This document is current as of February 8, 2019, except where otherwise stated. The information contained
More informationZenabis November 21, 2018
Zenabis November 21, 2018 Disclaimers IMPORTANT: YOU MUST READ THE FOLLOWING BEFORE CONTINUING. The information contained in this document has been prepared by Sun Pharm Investments Ltd. ( Sun Pharm or
More informationI n v e s t o r P r e s e n t a t i o n A c q u i s i t i o n o f C a n n a F a r m s
I n v e s t o r P r e s e n t a t i o n A c q u i s i t i o n o f C a n n a F a r m s July 30, 2018 TSX-V: VIVO OTCQB: ABCCF Disclaimer Certain information included in this presentation, which was prepared
More informationPREMIUM MEDICAL CANNABIS POWERED BY SUNLIGHT
PREMIUM MEDICAL CANNABIS POWERED BY SUNLIGHT Q2 2018 Investor Presentation PREMIUM January MEDICAL CANNABIS 10, 2018 POWERED BY SUN DISCLAIMER This documentation is a presentation (the Presentation ) of
More informationCannTrust Holdings Inc.
29 August 2017 Special Situations CannTrust Holdings Inc. The Pharmaceuticalization of Medical Cannabis TRST-CSE: $2.30 Speculative Buy $6.25 Target Initiating Coverage: We are initiating coverage on CannTrust
More informationDRIVING THE GLOBAL CANNABIS INDUSTRY. February 2019
DRIVING THE GLOBAL CANNABIS INDUSTRY February 2019 FORWARD-LOOKING STATEMENT This presentation contains forward-looking information within the meaning of applicable Canadian securities laws and forward-looking
More informationDISCLAIMER LIBERTY HEALTH SCIENCES INC. I INVESTORS PRESENTATION 2
DISCLAIMER This documentation is a presentation (the Presentation ) of general background information about Liberty Health Sciences Inc. s ( Liberty Health Sciences ) activities current as of September
More informationGlobal Leader in Medical Cannabis Created by Aphria & Nuuvera Combination. January 29, 2018
Global Leader in Medical Cannabis Created by Aphria & Nuuvera Combination January 29, 2018 Disclaimer This documentation is a presentation (the Presentation ) of general background information about Aphria
More informationDRIVING THE GLOBAL CANNABIS INDUSTRY
DRIVING THE GLOBAL CANNABIS INDUSTRY The 14 th Regional Investments & Capital Markets Conference of the Jamaica Stock Exchange January 2019 FORWARD-LOOKING STATEMENT This presentation contains forward-looking
More informationDRIVING THE GLOBAL CANNABIS INDUSTRY. Bruce Linton Chairman, Founder & Co-CEO February 2019
DRIVING THE GLOBAL CANNABIS INDUSTRY Bruce Linton Chairman, Founder & Co-CEO February 2019 FORWARD-LOOKING STATEMENT This presentation contains forward-looking information within the meaning of applicable
More informationPREMIUM MEDICAL CANNABIS POWERED BY SUNLIGHT
PREMIUM MEDICAL CANNABIS POWERED BY SUNLIGHT Q2 2018 Investor Presentation PREMIUM January MEDICAL CANNABIS 10, 2018 POWERED BY SUN DISCLAIMER This documentation is a presentation (the Presentation ) of
More informationCorporate Presentation November 2017
Investing In High Yield Businesses Around The Globe Corporate Presentation November 2017 Disclaimer This presentation ( Presentation ) is provided on the basis that neither LGC Capital Ltd) (the Company
More informationA Powerful Strategic Combination
A Powerful Strategic Combination Forward Looking Statements This Presentation (the Document ) by Aurora Cannabis Inc. ( Aurora or the Company ) has been compiled by management of the Company solely for
More informationInvestor Presentation
Investor Presentation 23 January 2019 2019 MMJ Group Holdings Limited ASX: MMJ www.mmjgh.com.au MMJ Group Holdings Limited Global cannabis investment company Corporate Details Portfolio Investment Approach
More informationCSE:CRZ 1 OTCQX:CNNRF
CSE:CRZ OTCQX:CNNRF 1 INVESTOR PRESENTATION STOCK DISCLAIMERS Forward Looking Information This investor presentation dated November 2017 (the Presentation ) contains forward-looking information regarding
More informationWe Have A Good Thing Growing
This documentation is a presentation (the Presentation ) of general background information about Aphria Inc. s ( Aphria ) activities current as of April 16, 2018, unless stated otherwise. It is information
More informationInvestor Presentation January CSE ticker: GW
Investor Presentation January 2019 CSE ticker: GW 2 NOTICE TO RECIPIENT This investment is suitable only for sophisticated investors for whom an investment does not constitute a complete investment program,
More informationQ INVESTOR PRESENTATION. A Global Cannabis Leader
Q4 2018 INVESTOR PRESENTATION A Global Cannabis Leader July 31, 2018 This documentation is a presentation (the Presentation ) of general background information about Aphria Inc. s ( Aphria ) activities
More informationDISCLAIMER STATEMENTS
January 2019 DISCLAIMER STATEMENTS This presentation relates to an entity that is directly involved in the United States cannabis industry insofar as its business activities include the cultivation, production,
More informationTHC Quarterly Update and Appendix 4C
www.thcl.com.au ASX RELEASE (31 OCTOBER 2018) To be renamed THC Global Group Limited (subject to shareholder approval) THC Quarterly Update and Appendix 4C The Hydroponics Company Limited, to be renamed
More informationInvestor Presentation
Investor Presentation 31 August 2018 2018 MMJ PhytoTech Limited ASX: MMJ www.mmjphytotech.com.au MMJ Global cannabis investment company Listed on the ASX and trades with the code MMJ Circa 16,000 shareholders;
More informationQUARTERLY ACTIVITIES REPORT FOR THE PERIOD ENDED 30 SEPTEMBER 2017
31 October 2017 QUARTERLY ACTIVITIES REPORT FOR THE PERIOD ENDED 30 SEPTEMBER 2017 MMJ PhytoTech Limited (ASX: MMJ) ( MMJ or the Company ) is pleased to provide its quarterly activities report for the
More informationCONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) EMBLEM CORP. FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2018
CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) OF EMBLEM CORP. FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2018 NOTICE OF UNAUDITED CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS
More informationCorporate Presentation
Corporate Presentation APRIL 2018 OTCQB: AGTK 1 INVESTOR PRESENTATION STOCK DISCLAIMERS Forward Looking Information This investor presentation dated April 2018 (the Presentation ) contains forward-looking
More informationMANAGEMENT S DISCUSSION AND ANALYSIS EMBLEM CORP. FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2018
OF EMBLEM CORP. FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2018 This Management s Discussion and Analysis ( MD&A ) of Emblem Corp. and its subsidiary companies (collectively, Emblem or the Company ) provides
More informationDRIVING THE GLOBAL CANNABIS INDUSTRY. Bruce Linton Founder, Chairman & Co-CEO November 2018
DRIVING THE GLOBAL CANNABIS INDUSTRY Bruce Linton Founder, Chairman & Co-CEO November 2018 FORWARD-LOOKING STATEMENT This presentation contains forward-looking information within the meaning of applicable
More informationFor personal use only
Quarterly Activities Report and Quarter ended September 2018 ASX RELEASE On track for launch of validated cannabinoid medicines in 2019 Highlights Completion of successful pilot production of AusCann s
More informationCORPORATE PRESENTATION CANADA S CANNABIS COMPANY
CORPORATE PRESENTATION CANADA S CANNABIS COMPANY LEGAL DISCLAIMER NOTICE TO RECIPIENT This investment is suitable only for sophisticated investors for whom an investment does not constitute a complete
More informationCORPORATE PRESENTATION
CORPORATE PRESENTATION OCTOBER 2018 CSE: CHM OTCQB: CHMJF FORWARD LOOKING STATEMENTS This corporate document contains forward-looking statements and forward-looking information (collectively, forward-looking
More informationCorporate Presentation March 2018
Rapidly Creating a Global Cannabis Supplier Corporate Presentation March 2018 Disclaimer This presentation ( Presentation ) is provided on the basis that neither LGC Capital Ltd. ( LGC ) nor its officers,
More informationFor personal use only
Appendix 4E and Preliminary Unaudited Financial Report 30 June 2018 AusCann Group Holdings Limited provides the following information under listing rule 4.3A: Details of the reporting period and the previous
More informationSecureLink Q Financial Results
SecureLink Q1 2018 Financial Results Unaudited May 31 st, 2018 Disclaimer Important information This Presentation (the "Presentation ) has been produced by SL Bidco B.V. (the "Issuer" or "SecureLink",
More informationCannabics Pharmaceuticals, Inc. Breakthrough Cannabis Medications - Review and Outlook.
Cannabics Pharmaceuticals, Inc. Breakthrough Cannabis Medications - Review and Outlook. Cannabics Pharmaceuticals, Inc. (OTCQB: CNBX), is engaged in the development of Personalized Anti- Cancer treatments.
More informationOVERVIEW OF GREENSPACE BRANDS ACQUISITION OF US BASED GALAXY
OVERVIEW OF GREENSPACE BRANDS ACQUISITION OF US BASED GALAXY NUTRITIONAL FOODS INC. ( GO VEGGIE ) December 20 th 2017 DISCLAIMER Forward Looking Information Certain statements in this press release may
More informationAuxly Corporate Overview
Auxly Corporate Overview 2018 Financial and Operational Highlights Legal Disclaimer The information provided herein is not intended to provide financial, tax, legal or accounting advice. The contents hereof
More informationOverview September, 2018
Overview September, 2018 A preliminary prospectus (the Prospectus ) containing important information relating to the securities described in this document has been filed with the securities regulatory
More informationFor personal use only
ASX RELEASE AusCann Strengthens Key Partnerships in March Quarter Highlights Australia AusCann welcomed the Australian Government s decision to allow cannabinoid medicines to be exported AusCann has entered
More informationEmerald Health Therapeutics Reports 1 st Quarter 2018 Financial Results and Provides Corporate Update
Emerald Health Therapeutics Reports 1 st Quarter 2018 Financial Results and Provides Corporate Update Commences commercial production at its Pure Sunfarms Delta 3 joint venture greenhouse operation VICTORIA,
More informationHighlights for Village Farms U.S. Hemp/CBD Initiative
Village Farms International Reports Fourth Quarter and Year End 2018 Financial Results Cannabis Joint Venture, Pure Sunfarms, Generates Positive Net Income in First Full Quarter of Sales and for the Full
More informationEMERALD HEALTH THERAPEUTICS, INC. MANAGEMENT DISCUSSION AND ANALYSIS For the three and nine months ended September 30, 2017
EMERALD HEALTH THERAPEUTICS, INC. MANAGEMENT DISCUSSION AND ANALYSIS For the three and nine months ended September 30, 2017 Dated: November 15, 2017 - 2 - TABLE OF CONTENTS Forward-Looking Statements...
More informationNOV E M B E R Life better lived. EMBLEM CORP. TSXV: EMC
NOV E M B E R 20 1 8 Life better lived. EMBLEM CORP. TSXV: EMC TSXV : EM C 2 DISCLAIMER AS OF OCTOBER 10, 2018 This documentation is a presentation (the Presentation ) of general background information
More informationPROSPECTUS. 12,584,100 Common Shares on exercise or deemed exercise of 12,584,100 Outstanding Special Warrants
No securities regulatory authority has expressed an opinion about any information contained herein and it is an offence to claim otherwise. This prospectus constitutes a public offering of these securities
More informationCANNABIS WHEATON INCOME CORP. MANAGEMENT S DISCUSSION AND ANALYSIS OF FINANCIAL RESULTS FOR THE PERIOD ENDED MARCH 31, Stated in Canadian Funds
CANNABIS WHEATON INCOME CORP. MANAGEMENT S DISCUSSION AND ANALYSIS OF FINANCIAL RESULTS FOR THE PERIOD ENDED MARCH 31, 2018 Stated in Canadian Funds DATE: MAY 30, 2018 For the Period Ended March 31, 2018
More information(TSXV: LABS) MEDIPHARM LABS CORP. MANAGEMENT S DISCUSSION AND ANALYSIS FOR THE YEAR ENDED DECEMBER 31, 2018
(TSXV: LABS) MEDIPHARM LABS CORP. FOR THE YEAR ENDED DECEMBER 31, 2018 April 3, 2019 This management s discussion and analysis ( MD&A ) of the financial condition and performance of (the Company ) was
More informationTHE AURORA STANDARD QUALITY AGILITY INNOVATION EXECUTION EXPANSION. Acquisition of CanniMed Therapeutics. March 2018
THE AURORA STANDARD QUALITY AGILITY INNOVATION EXECUTION EXPANSION Acquisition of CanniMed Therapeutics March 2018 Forward Looking Statements This presentation (the Document ) by Aurora Cannabis Inc. (
More informationDISCLAIMER STATEMENTS
November 2018 DISCLAIMER STATEMENTS This presentation relates to an entity that is directly involved in the United States cannabis industry insofar as its business activities include the cultivation, production,
More informationEMERALD HEALTH THERAPEUTICS, INC.
EMERALD HEALTH THERAPEUTICS, INC. MANAGEMENT DISCUSSION AND ANALYSIS For the three and six months ended June 30, 2018 Dated: August 29, 2018-1 - TABLE OF CONTENTS Forward-Looking Statements... 3 Overview...
More informationInvestment for the Canadian Recreational Cannabis Market
CANOPY GROWTH CORPORATION REPORTS FOURTH QUARTER AND FISCAL YEAR 2018 FINANCIAL RESULTS: DRIVING READINESS FOR THE CANADIAN RECREATIONAL CANNABIS MARKET Total licensed footprint exceeding 2.4 million sq.
More informationCSE FORM 2A LISTING STATEMENT
TERRASCEND CORP. CSE FORM 2A LISTING STATEMENT APRIL 26, 2017 TABLE OF CONTENTS 1. GLOSSARY... 3 2. CORPORATE STRUCTURE... 4 3. GENERAL DEVELOPMENT OF THE BUSINESS... 5 4. NARRATIVE DESCRIPTION OF THE
More informationCorporate Presentation Investor Relations Second Quarter 2017
Corporate Presentation Investor Relations Second Quarter 2017 Disclaimer Statements made in this presentation relate to CCU s future performance or financial results are forward-looking statements within
More informationCorporate Presentation Investor Relations Fourth Quarter 2016
Corporate Presentation Investor Relations Fourth Quarter 2016 Disclaimer Statements made in this presentation relate to CCU s future performance or financial results are forward-looking statements within
More informationVIVO CANNABIS INC. (formerly ABcann Global Corporation) Management s Discussion & Analysis. For the Three and Six Months Ended June 30, 2018
VIVO CANNABIS INC. (formerly ABcann Global Corporation) Management s Discussion & Analysis For the Three and Six Months Ended June 30, 2018 August 29, 2018 Introduction This management s discussion and
More informationMANAGEMENT S DISCUSSION & ANALYSIS
MANAGEMENT S DISCUSSION & ANALYSIS This management discussion and analysis ( MD&A ) of the financial condition and results of operations of Aphria Inc., (the Company or Aphria ), is for the three and twelve
More informationMolsidomine 2mg / 4mg Tablets
Molsidomine 2mg / 4mg Tablets, Molsidomine 2mg / 4mg Tablets India, Molsidomine 2mg / 4mg Tablets manufacturers India, side effects Molsidomine 2mg / 4mg Tablets manufacturers, Taj Pharma India, Molsidomine
More informationDRIVING THE GLOBAL CANNABIS INDUSTRY. February 2018
DRIVING THE GLOBAL CANNABIS INDUSTRY February 2018 FORWARD-LOOKING STATEMENT This presentation contains forward-looking information within the meaning of applicable Canadian securities laws and forward-looking
More informationDISCLAIMER LIBERTY HEALTH SCIENCES INC. I INVESTORS PRESENTATION 2
DISCLAIMER This documentation is a presentation (the Presentation ) of general background information about Liberty Health Sciences Inc. s ( Liberty Health Sciences ) activities current as of July 7, 2017.
More informationEMBLEM CORP. MANAGEMENT S DISCUSSION AND ANALYSIS For the year ended December 31, 2016
MANAGEMENT S DISCUSSION AND ANALYSIS CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This Management s Discussion and Analysis [ MD&A ] of Emblem Corp. [ Emblem or the Company ] contains forward-looking
More informationGLOBAL LEADER IN MEDICAL CANNABIS CREATED BY APHRIA AND NUUVERA COMBINATION
GLOBAL LEADER IN MEDICAL CANNABIS CREATED BY APHRIA AND NUUVERA COMBINATION Combination capitalizes on Nuuvera s expansive international footprint, expanding network into Europe, Africa and the Middle
More informationInvestor Presentation May September 2017
Investor Presentation May 2018 September 2017 Forward Looking Statements 2 This presentation contains certain "forward looking statements". These statements relate to future events or future performance
More informationMEDRELEAF CORP. ANNUAL INFORMATION FORM. For the fiscal year ended March 31, 2017
MEDRELEAF CORP. ANNUAL INFORMATION FORM For the fiscal year ended March 31, 2017 Dated: June 27, 2017 TABLE OF CONTENTS ANNUAL INFORMATION FORM... 1 FORWARD LOOKING INFORMATION... 1 CORPORATE STRUCTURE...
More informationFor personal use only
CAPITAL MINING ENTERS INTO NON-BINDING CONDITIONAL TERM SHEET TO ACQUIRE 100% OF TASMANIAN BASED COMPANY, CANNABINOID EXTRACTS AUSTRALIA PTY LTD Capital Mining Limited ASX: CMY, CMYO Level 11, 216 St Georges
More informationTHE FUTURE IS ORGANIC INDUSTRY LEADER IN LOW-COST, CERTIFIED ORGANIC CANNABIS PRODUCTION
THE FUTURE IS ORGANIC INDUSTRY LEADER IN LOW-COST, CERTIFIED ORGANIC CANNABIS PRODUCTION August 2018 Disclaimer This presentation is not, and under no circumstances is to be construed as, a prospectus,
More informationCREATING A NORTH AMERICAN CANNABIS POWERHOUSE APRIL 2019
CREATING A NORTH AMERICAN CANNABIS POWERHOUSE APRIL 2019 DISCLAIMER This presentation contains forward-looking information within the meaning of applicable Canadian securities legislation and may also
More informationCRONOS GROUP INC. Management s Discussion and Analysis of Financial Condition and Results of Operations. For the First Quarter Ended March 31, 2018
CRONOS GROUP INC. Management s Discussion and Analysis of Financial Condition and Results of Operations For the First Quarter Ended March 31, 2018 (in thousands of Canadian dollars) GENERAL MATTERS This
More informationEMERALD HEALTH THERAPEUTICS, INC.
EMERALD HEALTH THERAPEUTICS, INC. MANAGEMENT DISCUSSION AND ANALYSIS For the three months ended March 31, 2018 Dated: May 28, 2018-1 - TABLE OF CONTENTS Forward-Looking Statements... 3 Overview... 5 Recent
More informationCorporate Presentation Investor Relations Third Quarter 2017
Corporate Presentation Investor Relations Third Quarter 2017 Disclaimer Statements made in this presentation relate to CCU s future performance or financial results are forward-looking statements within
More informationINVESTOR PRESENTATION. June 01, 2018 CSE: CALI OTCQB: FNNZF
INVESTOR PRESENTATION June 01, 2018 CSE: CALI OTCQB: FNNZF DISCLAIMER Cautionary Note Regarding Forward-Looking Information These materials include forward-looking statements. Such statements are based
More informationTHE GREEN ORGANIC DUTCHMAN HOLDINGS LTD. PROVIDES SHAREHOLDER UPDATE AND ANNOUNCES $10 MILLION NON-BROKERED FINANCING
THE GREEN ORGANIC DUTCHMAN HOLDINGS LTD. PROVIDES SHAREHOLDER UPDATE AND ANNOUNCES $10 MILLION NON-BROKERED FINANCING Dear Shareholders, It is with great pleasure that I address you today as shareholders
More informationElixinol Global Limited
Elixinol Global Limited FY2017 Results Presentation For the year ending 31 December 2017 DRAFT 27 February 2018 Disclaimer This presentation contains summary information about Elixinol Group Limited (Elixinol)
More informationCorporate Presentation
Corporate Presentation April 2018 CSE: CRZ OTCQX: CNNRF INVESTOR PRESENTATION STOCK DISCLAIMERS Forward Looking Information This investor presentation dated March 2018 (the Presentation ) contains forward-looking
More informationCanada Leads the Global Cannabis Paradigm Shift
Canada Leads the Global Cannabis Paradigm Shift Initiating Aphria and Canopy at Outperform May 2018 Tamy Chen, CFA Cannabis Analyst BMO Nesbitt Burns Inc. (416) 359-5501 tamy.chen@bmo.com Peter Sklar,
More informationCORPORATE PRESENTATION
CORPORATE PRESENTATION November 2018 Delivering Long-term Success in Cannabis Investing CSE : CGOC cgocorp.com 1 Disclaimer Terms undefined herein have the meanings ascribed to them in the Prospectus.
More informationSecureLink Cybersecurity Services FY 2017 Financial Results Unaudited
SecureLink Cybersecurity Services FY 2017 Financial Results Unaudited April 23th, 2018 Disclaimer Important information This Presentation (the Presentation") has been produced by SL Bidco B.V. (the Group,
More informationLOON ENERGY CORPORATION AGREES TO AMALGAMATION WITH EMERGING CANNABIS COMPANY
LOON ENERGY CORPORATION AGREES TO AMALGAMATION WITH EMERGING CANNABIS COMPANY Calgary, Alberta: September 17, 2018 Loon Energy Corporation (NEX: LNE.H) ( Loon ) announces that it has entered into an Amalgamation
More informationCorporate Presentation
Corporate Presentation March 2018 CSE: CRZ OTCQX: CNNRF 0 INVESTOR PRESENTATION STOCK DISCLAIMERS Forward Looking Information This investor presentation dated March 2018 (the Presentation ) contains forward-looking
More informationInvestor Presentation March September 2017
Investor Presentation March 2018 September 2017 Forward Looking Statements 2 This presentation contains certain "forward looking statements". These statements relate to future events or future performance
More informationInvestor Presentation February September 2017
Investor Presentation February 2018 September 2017 Forward looking statements 2 This presentation contains certain "forward looking statements". These statements relate to future events or future performance
More informationCorporate Presentation Investor Relations Fourth Quarter 2017
Corporate Presentation Investor Relations Fourth Quarter 2017 Disclaimer Statements made in this presentation relate to CCU s future performance or financial results are forward-looking statements within
More informationCorporate Presentation. Investor Relations Second Quarter 2018
Corporate Presentation Investor Relations Second Quarter 2018 Disclaimer Statements made in this presentation relate to CCU s future performance or financial results are forward-looking statements within
More informationMANAGEMENT S DISCUSSION AND ANALYSIS EMBLEM CORP. FOR THE THREE MONTHS ENDED MARCH 31, 2018
OF EMBLEM CORP. FOR THE THREE MONTHS ENDED MARCH 31, 2018 This Management s Discussion and Analysis ( MD&A ) of Emblem Corp. and its subsidiary companies (collectively, Emblem or the Company ) provides
More informationHikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC This document, which has been issued by Hikma Pharmaceuticals PLC (the Company ), comprises the written materials/slides for a presentation. This document and its contents are
More informationCanopy Growth Corporation (Formerly Tweed Marijuana Inc.)
Canopy Growth Corporation (Formerly Tweed Marijuana Inc.) Management s Discussion and Analysis of the Financial Condition and Results of Operations For the three and six months ended September 30, 2015
More informationThe Proposed Acquisition. Fruité Entreprises SA
The Proposed Acquisition Of Fruité Entreprises SA 1 This presentation does not constitute an offer to sell or issue or the solicitation of an offer to buy or subscribe for the securities mentioned herein
More informationHarvest One Cannabis Inc. Management s Discussion and Analysis
Harvest One Cannabis Inc. Management s Discussion and Analysis For the three months ended September 30, 2018 INTRODUCTION This Management s Discussion and Analysis ( MD&A ) should be read in conjunction
More informationOverview September, 2018
Overview September, 2018 A preliminary prospectus (the Prospectus ) containing important information relating to the securities described in this document has been filed with the securities regulatory
More informationianthus Capital Acquires Medical Cannabis Business of GrowHealthy Holdings, Marking Full-Scale Entry into Fast Growing Florida Market
January 17, 2018 ianthus Capital Acquires Medical Cannabis Business of GrowHealthy Holdings, Marking Full-Scale Entry into Fast Growing Florida Market Company to Host a Conference Call at 4:20 PM ET on
More informationMANAGEMENT DISCUSSION AND ANALYSIS
MANAGEMENT DISCUSSION AND ANALYSIS INVESTOR RELATIONS TRANSFERT AGENT Jennifer Smith TSX Trust Company 1-866-600-5869 tmxeinvestorservices@tmx.com Manager of Financial Reporting & Investor Relations 1-866-438-8429
More informationGolden Leaf Reports Fiscal First Quarter 2018 Results
Golden Leaf Reports Fiscal First Quarter 2018 Results Toronto, Ontario May 30, 2018 Golden Leaf Holdings Ltd. ( Golden Leaf or the Company ) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company
More informationFor personal use only
ASX Release 23 April 2018 CannPal Animal Therapeutics Limited ACN: 612 791 518 ASX:CP1 CannPal 4C Quarterly Cash Flow Report Highlights for the quarter ending 31 March 2018 Secured all domestic and international
More informationCANOPY GROWTH CORPORATION
CANOPY GROWTH CORPORATION MANAGEMENT S DISCUSSION AND ANALYSIS OF THE FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2017 NOVEMBER 13, 2017 Canopy Growth
More informationDelivering our Global Growth Strategy. Proposed Acquisition of AST Farma and Le Vet Beheer
Delivering our Global Growth Strategy Proposed Acquisition of AST Farma and Le Vet Beheer Disclaimer NOT FOR REDISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OR ANY OTHER
More informationMaricann Group Inc. Management's Discussion and Analysis of Financial Condition and Results of Operations
Maricann Group Inc. Management's Discussion and Analysis of Financial Condition and Results of Operations For the Three and Six Months Ended June 30, 2018 and 2017 MARICANN GROUP INC. Management's Discussion
More informationT 9. Harvest One Cannabis Inc. Management s Discussion and Analysis
T 9 Harvest One Cannabis Inc. Management s Discussion and Analysis For the three and six months ended December 31, 2018 INTRODUCTION This Management s Discussion and Analysis ( MD&A ) should be read in
More informationCorporate Presentation. Investor Relations Third Quarter 2018
Corporate Presentation Investor Relations Third Quarter 2018 Disclaimer Statements made in this presentation relate to CCU s future performance or financial results are forward-looking statements within
More information